ストックスクリーナーアプリを入手
0.144
8.69%
-0.0137
プレマーケット:
.14
-0.004
-2.78%
前日終値:
$0.1577
開ける：
$0.1571
24時間の取引高:
3.87M
Relative Volume:
0.37
時価総額：
$19.52M
収益：
$1.73M
当期純損益:
$-23.50M
株価収益率:
-0.6593
EPS:
-0.2184
ネットキャッシュフロー:
$-19.37M
1週間 パフォーマンス:
-18.27%
1か月 パフォーマンス:
-29.89%
6か月 パフォーマンス:
-66.12%
1年 パフォーマンス:
-70.00%
1日の値動き範囲:
$0.14
$0.1571
1週間の範囲:
$0.14
$0.1825
52週間の値動き範囲:
$0.14
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
名前
VolitionRX Ltd
セクター
電話
646 650 1351
住所
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.144 | 21.28M | 1.73M | -23.50M | -19.37M | -0.2184 |
TMO
Thermo Fisher Scientific Inc
|
466.70 | 194.94B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
178.57 | 137.69B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.93 | 45.19B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.42 | 34.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
311.20 | 32.91B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-08 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-01 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 開始されました | Maxim Group | Buy |
| 2018-05-14 | 繰り返されました | The Benchmark Company | Buy |
| 2016-09-07 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-02-01 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
VolitionRX Ltd (VNRX) 最新ニュース
VolitionRx Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
VolitionRx (NYSE: VNRX) wins NYSE American time to fix listing - Stock Titan
VolitionRx receives NYSE American compliance plan approval By Investing.com - Investing.com Canada
VolitionRx Announces Acceptance of Compliance Plan by NYSE American - Yahoo Finance Singapore
D Boral Capital downgrades VolitionRx (VNRX) - MSN
VolitionRx launches online shop for recombinant nucleosomes By Investing.com - Investing.com Australia
VNRX Downgraded by D. Boral Capital -- Rating Changed to Hold - GuruFocus
VolitionRx Ltd stock (US92852X1037): Does its blood-testing tech unlock real diagnostic upside? - AD HOC NEWS
D. Boral Capital downgrades VolitionRX stock rating on reverse split By Investing.com - Investing.com South Africa
D. Boral Capital Downgrades VolitionRX(VNRX.US) to Hold Rating - Moomoo
After building for 10 years, Volition puts nucleosomes up for sale online - Stock Titan
VolitionRx Limited Files Form 8-K With SEC Detailing Company Information and Compliance Data - Minichart
VolitionRx Ltd stock (US92852X1037): Is its blood-testing breakthrough strong enough to unlock inves - AD HOC NEWS
VolitionRx (VNRX) to execute 1-for-20 reverse stock split on April 28, 2026 - Stock Titan
VNRX Should I Buy - Intellectia AI
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
VolitionRx Ltd stock (US92852X1037): Why does its blood-testing innovation matter more now for U.S. - AD HOC NEWS
H.C. Wainwright cuts VolitionRX stock price target to $1 on share count - Investing.com Australia
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain - TipRanks
VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK
VNRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VolitionRX (VNRX) FY2025 Earnings: Q4 EPS and Revenue Not Disclo - GuruFocus
VolitionRX Is Maintained at Buy by HC Wainwright & Co. - Moomoo
VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript - Insider Monkey
VolitionRX Q4 Earnings Call Highlights - Defense World
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong R - GuruFocus
VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut - TipRanks
VolitionRX (VNRX) Sees Target Price Cut Despite Maintained Buy R - GuruFocus
VolitionRx Limited (VNRX) 8-K SEC Filing March 31, 2026: Company Details, Address, and Stock Information - Minichart
VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results By Investing.com - Investing.com South Africa
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results - Investing.com
Q4 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus
VolitionRx : Corporate Presentation April 2026 - marketscreener.com
VolitionRX's Nu.Q Cancer Reimbursement Decision in Q4 2026 Could Unlock Commercial Licensing Momentum Amid Dilution Risks - Bitget
VolitionRx secures €2M in Belgian government financing By Investing.com - Investing.com South Africa
Volitionrx Ltd earnings beat, revenue fell short of estimates By Investing.com - Investing.com India
Volitionrx Ltd earnings beat, revenue fell short of estimates - Investing.com UK
VolitionRX Q4 2025 Earnings Call Transcript - MarketBeat
VolitionRX: Q4 Earnings Snapshot - theheraldreview.com
VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital | - GuruFocus
VolitionRx (NYSE: VNRX) details going concern risk, funding needs and Nu.Q® rollout - Stock Titan
Volition says its tests are nearing hospital use in lung cancer and sepsis - Stock Titan
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital - Moomoo
VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Belgian agencies give VolitionRx €2M to advance tests for poorer countries - Stock Titan
VolitionRx biomarkers show elevation in trauma patients study By Investing.com - Investing.com South Africa
VolitionRX Ltd (VNRX) 財務データ
収益
当期純利益
現金流量
EPS
2.82%
大文字化:
|
ボリューム (24 時間):